Marija Gjorgoska | Molecular Diagnostics | Best Researcher Award

Posted on by sciencefather

Ms. Marija Gjorgoska | Molecular Diagnostics | Best Researcher Award 

Asistant, at Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, Slovenia.

Marija Gjorgoska is a dedicated biochemist and molecular biologist specializing in cancer research and steroid hormone signaling. Currently a Teaching and Research Assistant at the Institute of Biochemistry and Molecular Genetics, Faculty of Medicine, University of Ljubljana, she contributes to both education and cutting-edge biomedical research. With a strong foundation in LC-MS/MS and bioinformatics, Marija’s work focuses on cancer tissue analysis and hormone-related pathophysiology. Her academic journey spans prestigious institutions in Slovenia, Spain, and Macedonia, earning top grades and fellowships. She has authored impactful scientific papers in high-impact journals and has trained internationally, including at the University of Birmingham. Marija combines analytical precision with a passion for advancing women’s health, particularly in gynecological cancers. Her work bridges bench research and clinical relevance, making her a valuable voice in molecular medicine. Fluent in four languages and equipped with versatile lab skills, Marija continues to contribute meaningfully to biomedical innovation. 🌍🧪📚

Professional Profile

Scopus

🎓 Education

Marija Gjorgoska’s academic journey is marked by interdisciplinary excellence. She is currently pursuing her PhD in Biomedicine with a focus on Biochemistry and Molecular Biology at the University of Ljubljana. Prior to this, she completed an MSc in Molecular Biology at the same university with a remarkable GPA of 9.52/10. Her academic endeavors also led her to Spain, where she earned an MSc in Neuroscience from Universidad Miguel Hernandez under the prestigious Severo Ochoa fellowship, graduating in the top 15% of her class. Her foundational education was a BSc in Biochemistry and Physiology at the University “Ss. Cyril and Methodius”, Macedonia, where she was recognized as the best student of her generation with a GPA of 9.74/10. Her diverse academic background across biochemistry, neuroscience, and molecular biology forms the basis of her integrative approach to biomedical research. 📖🧬🎓

🧪 Experience

Marija Gjorgoska currently holds dual roles at the University of Ljubljana’s Faculty of Medicine—as a Teaching Assistant and a Research Assistant. Since 2020, she has led critical efforts in LC-MS/MS method development and validation, genetic and proteomic cancer tissue analysis, and R-based bioinformatics. She actively supports literature review, manuscript preparation, and educational delivery. Her teaching spans courses such as Principles of Biochemistry and practical instruction for medical and PhD students in LC-MS/MS and steroid hormone biochemistry. Marija has also conducted laboratory teaching in General Biochemistry at her alma mater in Macedonia. Her professional development includes internships at the University of Birmingham’s Institute of Metabolism and the Macedonian Academy of Sciences and Arts, where she worked on rare diseases and HPV screening. Her hands-on expertise, leadership in research, and global training have made her an invaluable contributor to both education and science. 🔬📊👩‍🏫

🔬 Research Interests 

Marija’s research is rooted in translational biochemistry with a strong focus on hormonal signaling in cancer. She specializes in steroid hormones, particularly estrogen and androgens, and their role in gynecological malignancies such as ovarian and endometrial cancers. Her work employs advanced liquid chromatography-tandem mass spectrometry (LC-MS/MS) to simultaneously profile endogenous steroid hormones. In addition, she explores the tumor microenvironment, cancer metabolism, and pre-receptor regulation mechanisms. Her recent studies delve into multi-steroid profiling combined with machine learning to identify novel biomarkers, demonstrating her innovative approach. She is also involved in Mendelian randomization to explore causal links between hormones and disease subtypes. Marija is deeply motivated to enhance the molecular understanding of hormone-related pathologies, aiming for clinical translation. Her interdisciplinary research bridges molecular biology, analytical chemistry, and bioinformatics, making significant contributions to cancer diagnostics and therapeutics. 🧬💉📈

🏆 Awards 

Marija Gjorgoska’s academic excellence and research innovation have been recognized through several prestigious awards. In 2023, she received the Practical Skills Grant from the Society of Endocrinology, UK, acknowledging her practical training in LC-MS/MS techniques. In 2021, her Master’s thesis on molecular biology earned her the Krka Recognition with Special Praise, awarded to outstanding postgraduate researchers in Slovenia. Her consistent top academic performance includes graduating among the top 15% in her neuroscience MSc program in Spain and being named the best student of the generation during her BSc studies in Macedonia. These honors reflect her exceptional academic record, technical expertise, and contributions to biomedical research. Her recognition at both national and international levels highlights her as a rising star in molecular medicine, particularly in cancer biochemistry and hormone signaling. 🏅🎖️📜

📚Top Noted  Publications 

✅ 1. Gjorgoska, M., & Lanišnik-Rižner, T. (2024)

Title: From fallopian tube epithelium to high-grade serous ovarian cancer
Journal: Progress in Lipid Research
Volume: 96
Article Number: 101302
DOI: 10.1016/j.plipres.2024.101302
Indexing: Cited in lipid metabolism and hormone-driven tumorigenesis literature.

✅ 2. Gjorgoska, M., & Lanišnik-Rižner, T. (2022)

Title: Integration of androgen hormones in endometrial cancer biology
Journal: Trends in Endocrinology and Metabolism
Volume: 33
Issue: 9
Pages: 639–651
DOI: 10.1016/j.tem.2022.06.005
Indexing: PubMed, Scopus, Web of Science

✅ 3. Lanišnik-Rižner, T., & Gjorgoska, M. (2024)

Title: Steroid sulfatase and sulfotransferases in gynecological cancers
Journal: Essays in Biochemistry
Article Code: EBC20230096
DOI: 10.1042/EBC20230096
Indexing: Biochemical Society journals, Web of Science

✅ 4. Gjorgoska, M., & Lanišnik-Rižner, T. (2021)

Title: Estrogens and the Schrödinger’s cat in ovarian tumors
Journal: Cancers
Volume: 13
Issue: 19
Article Number: 5011
DOI: 10.3390/cancers13195011
Indexing: PubMed Central, Scopus, DOAJ

✅ 5. Gjorgoska, M., Taylor, A.E., Smrkolj, Š., & Rižner, T.L. (2025)

Title: Multi-Steroid Profiling and Machine Learning in Endometrial Cancer
Journal: Cancers
Volume: 17
Article Number: 1679
DOI: 10.3390/cancers17061679
Indexing: Scopus, Web of Science, PubMed

✅ 6. Gjorgoska, M., & Lanišnik-Rižner, T. (2024)

Title: Simultaneous steroid hormone measurement via LC-MS/MS
Journal: Journal of Steroid Biochemistry and Molecular Biology
Volume: 243
Article Number: 106578
DOI: 10.1016/j.jsbmb.2024.106578
Indexing: PubMed, Scopus, Web of Science

✅ 7. Gjorgoska, M., Šturm, L., & Lanišnik-Rižner, T. (2024)

Title: Pre-receptor regulation of 11-oxyandrogens in endometrial cancer
Journal: Frontiers in Endocrinology
Volume: 15
DOI: 10.3389/fendo.2024.1282059
Indexing: PubMed Central, Web of Science

✅ 8. Marolt, N., Pavlič, R., Kreft, T., Gjorgoska, M., & Lanišnik-Rižner, T. (2024)

Title: Targeting estrogen metabolism in platinum-resistant ovarian cancer
Journal: Biomedicine & Pharmacotherapy
Volume: 177
Article Number: 117069
DOI: 10.1016/j.biopha.2024.117069
Indexing: Scopus, PubMed, Web of Science

✅ 9. Gjorgoska, M., & Lanišnik-Rižner, T. (In Press)

Title: Effect of androgens on endometriosis and ovarian neoplasms: A Mendelian randomization study
Journal: [Journal name not yet disclosed]
Status: In Press (2025 expected)
DOI: Pending
Indexing: Will be cited by GWAS-based hormonal disease studies.

Conclusion

Marija Gjorgoska exemplifies the qualities of a top-tier early-career researcher: intellectual rigor, consistent scholarly output, and growing leadership in cancer biochemistry. Her research contributions are both innovative and impactful, addressing real-world medical challenges with a solid methodological foundation.

Xiaoqiang Chang | Molecular Medicine | Best Research Article Award

Posted on by sciencefather

Dr. Xiaoqiang Chang | Molecular Medicine | Best Research Article Award 

Doctorate, at School of Pharmacy, China.

Dr. Xiaoqiang Chang (常小强) is a dedicated pharmaceutical researcher currently serving at the School of Pharmacy, Bengbu Medical College (蚌埠医科大学). He earned his Ph.D. and Master’s degrees in Traditional Chinese Pharmacy from the China Academy of Chinese Medical Sciences, and his Bachelor’s from Henan University of Chinese Medicine. His research is focused on innovative methodologies in medicinal compound synthesis, particularly in the field of natural products and green catalysis. With notable publications in Environmental Chemistry Letters, Advanced Synthesis & Catalysis, and Molecules, he has proven his expertise as a unique first author. His academic journey reflects a consistent commitment to advancing pharmaceutical sciences, combining electrochemical, chromatographic, and synthetic techniques to explore medicinal compounds. Dr. Chang also holds a Chinese patent on diphenyldiazepine derivatives. His contributions continue to bridge traditional Chinese medicine with modern pharmaceutical innovation. 🌿⚗️📚

Professional Profile

ORCID

🎓 Education 

Dr. Xiaoqiang Chang’s academic foundation is deeply rooted in Traditional Chinese Medicine. He began his journey at Henan University of Chinese Medicine (2013-2017), earning a Bachelor’s degree in Pharmaceutical Preparation of Traditional Chinese Medicine. Driven by a passion for scientific research, he pursued graduate studies at the prestigious China Academy of Chinese Medical Sciences, obtaining a Master’s degree (2017-2020) and then a Doctorate in Chinese Pharmacy (2020-2023). During his doctoral training, Dr. Chang focused on natural product chemistry and drug development, incorporating both ancient medicinal knowledge and modern synthetic chemistry. His academic track equipped him with cross-disciplinary skills in chromatography, catalysis, and compound synthesis. His research is characterized by a fusion of heritage and innovation, reinforcing the relevance of traditional medicine in contemporary pharmaceutical sciences. 🎓🔬📖

💼 Experience 

Dr. Chang began his professional research career as an Assistant Researcher at the Henan Academy of Sciences, specifically at the Biomass Pyrolysis Transformation Innovation Center (July 2023 – May 2024). Here, he investigated catalytic processes for converting biomass into pharmacologically active compounds, applying both chemical engineering and pharmaceutical expertise. In June 2024, he joined the School of Pharmacy, Bengbu Medical College, further expanding his work in drug development and compound synthesis. His transition from biomass research to pharmaceutical innovation reflects his versatile research capabilities. Despite not having postdoctoral experience, Dr. Chang has successfully led multiple projects and published extensively. His roles have not only included laboratory research but also academic mentorship and interdisciplinary collaboration, making him a rising figure in applied pharmaceutical sciences. 🔍🏥🧪

🔬 Research Interest 

Dr. Chang’s research interest lies at the intersection of natural product chemistry, electrochemical synthesis, and green pharmaceutical technology. He is particularly intrigued by boron-catalyzed hydrosulfonylation, [3+2] electrochemical cycloaddition, and chromatographic techniques for active compound analysis. His recent work has focused on discovering and optimizing synthesis routes for medicinally relevant heterocycles and sulfones. Dr. Chang is passionate about developing sustainable and selective synthetic pathways, aiming to minimize environmental impact while maximizing pharmaceutical efficacy. In addition, his background in Traditional Chinese Medicine enriches his understanding of herbal pharmacology, leading to a unique integration of ancient wisdom and modern methodology. This cross-disciplinary approach is evident in both his experimental design and publication record. His long-term vision is to establish eco-friendly, high-efficiency platforms for drug discovery from both synthetic and natural sources. 🌱🧬⚙️

🏆 Awards 

Although Dr. Chang has yet to receive national-level funding or formal academic awards, his contribution to pharmaceutical research has been formally recognized through intellectual property achievements. In June 2023, he co-authored a Chinese patent titled “二苯并二氮杂卓衍生物及其制备方法和应用” (Diphenyldiazepine derivatives and their preparation method and application), registered as CN202310743034.9. This patent underscores his ability to transition basic chemical findings into practical applications, a key metric in modern pharmaceutical evaluation. The novelty and application potential of the compound structure demonstrate both innovation and therapeutic foresight. While still early in his career, Dr. Chang’s consistent authorship as the sole first author across several high-impact journal articles signifies his scientific independence and leadership. His continued work promises future recognition and contributions to medical chemistry and drug discovery. 🧪📜🚀

📚 Top Noted Publications 

1.Title: Synthesis of branched allylic sulfones by regioselective boron-catalysed hydrosulfonylation
Journal: Environmental Chemistry Letters
Year: 2023
Volume: 21
Pages: 681–687
Citations: 7
Summary:
This paper reports a novel method for synthesizing branched allylic sulfones using a regioselective boron-catalyzed hydrosulfonylation reaction. The methodology showcases high efficiency and selectivity, contributing significantly to sustainable synthetic chemistry and green catalysis.

2.Title: Electrochemical [3+2] Cycloaddition of Anilines and 1,3‐Dicarbonyl Compounds
Journal: Advanced Synthesis & Catalysis
Year: 2022
Volume: 364(16)
Pages: 2865–2871
Citations: 12
Summary:
This article presents an electrochemical approach for [3+2] cycloaddition between anilines and 1,3-dicarbonyl compounds. It demonstrates a metal-free and environmentally friendly route, offering a valuable synthetic tool in heterocyclic chemistry.

3.Title: A novel flavanone from Thymus przewalskii
Journal: China Journal of Chinese Materia Medica (中国中药杂志)
Year: 2021
Volume: 46(1)
Pages: 125–129
Citations: 4
Summary:
This study details the isolation and structural elucidation of a new flavanone compound from Thymus przewalskii. The findings enhance understanding of the phytochemistry of traditional Chinese medicinal herbs.

4.Title: Determination of Thymol and Carvacrol in Thymi herba by UPC2
Journal: Molecules
Year: 2020
Volume: 25
Article Number: 502
Citations: 16
Summary:
This paper describes a fast and reliable ultra-performance convergence chromatography (UPC2) method to quantify thymol and carvacrol in Thymi herba. It is significant for quality control in herbal medicine and pharmaceutical applications.

5.Title: 地椒质量标准的研究 (Study on the Quality Standards of Di Jiao)
Journal: 中成药 (Chinese Patent Medicine)
Year: 2019
Volume: 41(8)
Pages: 1894–1898
Citations: 5
Summary:
This article explores the establishment of quality control standards for Di Jiao (地椒), a traditional Chinese medicinal material. It involves pharmacognostic and chemical evaluation techniques to ensure consistency and efficacy.

Conclusion

Dr. Xiaoqiang Chang demonstrates clear scientific excellence, with a consistent track record of innovative, independently-led publications in high-impact journals and contribution to intellectual property development. While additional involvement in research grants and broader academic leadership would strengthen the application, his current scholarly output makes him highly competitive for the Best Research Article Award. His first-author articles reflect originality, depth, and relevance—hallmarks of an outstanding candidate.

Alaa Eldeen Yassin | nanomedicine | Best Researcher Award

Posted on by sciencefather

Prof. Alaa Eldeen Yassin | nanomedicine | Best Researcher Award 

Professor of Pharmaceutics, at King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia.

Professor Alaa Eldeen Bakry Yassin is a distinguished Professor of Pharmaceutics at the College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS). With a career dedicated to advancing pharmaceutical sciences, he plays a pivotal role in shaping the Pharm D curriculum, coordinating core courses in pharmaceutics and pharmacokinetics. He has also led initiatives in nanomedicine and pharmaceutics, spearheading the proposal for a Master’s program. Through his research leadership, he has established a cutting-edge nano-drug delivery research line, successfully mentoring over 30 students and colleagues, and securing substantial research funding. Professor Yassin is a prolific contributor to the scientific community, with over 40 publications and conference presentations enhancing knowledge in drug delivery and nanotechnology.

Profile

Scopus

Google Scholar

ORCID 

Education

🎓 Professor Yassin has a strong academic foundation that underpins his research excellence in pharmaceutics. He earned his degrees in pharmaceutical sciences, focusing on innovative drug delivery methods and nanotechnology. His advanced training allowed him to pioneer controlled-release and nano-particulate systems, and his educational achievements have enabled him to contribute substantially to academia, mentoring numerous students and junior faculty. By developing expertise in advanced pharmaceutics and nanomedicine, Professor Yassin has established himself as a leader in drug formulation and delivery research, dedicated to enhancing patient treatment outcomes through innovative therapeutic methods.

Experience

🧑‍🏫 With over a decade of experience in pharmaceutics, Professor Yassin has demonstrated exceptional expertise in academia and research. At KSAU-HS, he coordinates core pharmaceutics courses, guiding students through critical aspects of pharmacokinetics and advanced drug delivery systems. His extensive involvement includes chairing research committees and leading nano-drug delivery projects. Over the past five years, he has supervised over 30 students and faculty members, and his guidance has led to significant advancements in nanomedicine. His commitment to education and research is further underscored by his role in securing grants for high-impact research in innovative drug delivery methods.

Research Interests

🔬 Professor Yassin’s research focuses on pioneering new drug delivery systems, especially targeting cancer nanomedicine. His primary interests include nano-particulate systems like solid lipid nanoparticles, polymeric nanoparticles, and hybrid nano-systems, which enhance the bioavailability and efficacy of poorly absorbed drugs. He explores diverse controlled-release and site-specific delivery mechanisms, including colon-targeted and transdermal systems, aiming to improve patient outcomes through innovative nanotechnology applications. His work in controlled release dosage forms and cancer-targeting therapies places him at the forefront of pharmaceutics, where he continuously contributes to transforming therapeutic efficacy in clinical settings.

Awards

🏆 Professor Yassin’s contributions have been widely recognized, earning him prestigious awards. In 2019, he received the Ministry of National Guard-Health Affairs Basic Research Track’s Researcher Award and the KSAU-HS President Award for Best Faculty. His groundbreaking research also garnered him the Kayyali Prize for Scientific Research by the Saudi Pharmaceutical Society in 2014. These accolades reflect his dedication to advancing pharmaceutical sciences, his role as an influential educator, and his ongoing commitment to innovative research, positioning him as a leader in pharmaceutics and nanomedicine.

Top Noted Publications

📚 Professor Yassin has authored numerous impactful publications in indexed journals, contributing to advancements in drug delivery and nanotechnology. Here are selected publications with links and citation counts:

  • Yassin, A.E., Fayed, B., & Tawfik, T.A. (2013). Enhancing The Stability of Recombinant Human Erythropoietin. LAP Lambert Academic Publishing. ISBN-10: 3659348554, ISBN-13: 978-3659348556.
  • Design and optimization of nanocapsule oral delivery system(s) for poorly
    absorbed drug, Research center of Pharmacy, KSU No. C.P.R.C. with total budget
    35,000 SR.
  • The development of new drug delivery system for diagnosis and treatment of
    colon cancer, King Abdulaziz city for science and technology No. AT-25-23 with
    total budget 880,286 SR.
  • Modified geometry three-layer tablet as a platform class II drugs zero order
    release system. King Abdullah International Medical Research Centre (KAIMRC),
    SP14-071 with total budget 29,567 SR.

Conclusion

Dr. Alaa Eldeen Bakry Yassin’s accomplishments in pharmaceutics and his pioneering work in nanomedicine make him a compelling candidate for the Best Researcher Award. His extensive funding record, significant publication output, and contributions to student and faculty mentorship underscore his influence in pharmaceutical sciences. With a continued focus on expanding his international partnerships and pursuing additional industry collaborations, Dr. Yassin is well-positioned to lead impactful advancements in nano-drug delivery. He is a deserving candidate who aligns well with the criteria for this award.

 

Adalberto Santos | Genetic Humana | Best Researcher Award

Posted on by sciencefather

Dr . Adalberto Santos | Genetic Humana | Best Researcher Award 

Doctor , Fiocruz , Brazil

Dr. Adalberto Rezende Santos is a leading researcher in Cellular and Molecular Biology with a distinguished career at the Oswaldo Cruz Foundation (Fiocruz). Since earning his Ph.D. in 1999, he has made significant contributions to public health, focusing on tuberculosis and immunology. Dr. Santos’s expertise in pharmacogenetics, molecular diagnostics, and the genetics of infectious diseases has established him as a prominent figure in the scientific community, with a recent emphasis on entrepreneurship.

Profile

ORCiD

Strengths for the Award

  1. Extensive Research Experience: Dr. Adalberto Rezende Santos has a distinguished career in Cellular and Molecular Biology with over two decades of research experience, primarily focusing on infectious diseases such as tuberculosis and leprosy. His work on the genetics of these diseases and the pharmacogenetics of drug response is highly relevant to global health.
  2. Significant Research Contributions: Dr. Santos has made substantial contributions to understanding the genetic factors influencing drug response and disease susceptibility. His work on the NAT2 gene’s genetic variability and its implications for various diseases stands out. The publication of high-impact research in reputed journals and authoring key textbooks further underscores his impact.
  3. Innovative Approach: His patent on NAT2-based polymorphisms reflects his innovative approach to personalized medicine, bridging the gap between genomic research and practical healthcare solutions.
  4. Leadership and Collaboration: Dr. Santos has held prominent positions, such as the Head of the Tuberculosis Research Laboratory at the Federal University of Rio de Janeiro. His collaborative projects with international institutions, like Cornell University and Laval University, show his ability to lead and work in multidisciplinary teams.
  5. Academic Mentorship: His role in academic mentoring and scientific coordination has been instrumental in fostering new talents in Brazil, furthering the field of immunogenetics and pharmacogenetics.

Areas for Improvement 

  1. Citation Impact: While individual publications have citations, a more substantial cumulative citation index or h-index might strengthen his nomination. Highlighting these metrics would emphasize the broader influence of his research.
  2. Broader Dissemination of Research: Expanding the reach of his research through more international conferences or symposiums could enhance visibility and impact.
  3. Public Engagement: Increasing engagement with the public and policymakers could amplify the practical applications of his research in public health.

    Education

    Dr. Santos earned his Ph.D. in Cellular and Molecular Biology from the Oswaldo Cruz Foundation in 1999. His academic journey has been marked by a deep commitment to understanding the genetic factors influencing infectious diseases, shaping his innovative approaches to public health.

     Experience

    Dr. Santos has over two decades of experience as a Senior Researcher at the Oswaldo Cruz Foundation. He has led several research units dedicated to tuberculosis and immunology, and served as a scientific coordinator and external advisor, contributing to numerous scientific networks and collaborations globally.

    Research Interests

    Dr. Santos’s research interests encompass pharmacogenetics, molecular diagnostics, and the genetics of infectious diseases, with a particular focus on tuberculosis and leprosy. His work in these areas has paved the way for advancements in personalized medicine and public health strategies.

     Awards

    Dr. Santos has been recognized for his groundbreaking work in pharmacogenetics and molecular diagnostics. His contributions have earned him various awards and nominations, reflecting his impact on global health and science.

    Publications

    Dr. Santos has published extensively in high-impact journals such as PLoS ONE, BMC Genetics, and The Journal of Infectious Diseases. His notable publications include:

    1. Pharmacogenomics and Pharmacogenetics in Drug Therapy – InTech, 2021, ISBN: 9781837685271
    2. Tuberculosis – Current Issues in Diagnosis and Management – InTech, 2015, ISBN: 9789535110491
    3. International Textbook of Leprosy – American Leprosy Missions, 2020

      Conclusion

      Dr. Adalberto Rezende Santos is a highly suitable candidate for the Best Researcher Award, given his extensive contributions to infectious disease research, particularly in the genetics of tuberculosis and leprosy. His innovative work in pharmacogenetics and leadership in the scientific community underscore his qualifications. Addressing the areas of improvement could further strengthen his application, but his current achievements already make him a compelling candidate for the award.

sangeeta singh | stem cell biology | Best Researcher Award

Posted on by sciencefather

Dr.sangeeta singh | stem cell biology | Best Researcher Award 

Assistant Professor IIIT ALLAHABAD India

Evaluation of Dr. Sangeeta Singh for Best Researcher Award

Strengths for the Award

  1. Academic and Professional Background:
    • Dr. Sangeeta Singh is an Assistant Professor at the Indian Institute of Information Technology Allahabad (IIIT-A) with a solid academic background in Life Sciences and post-doctoral experience at ICAR-Indian Veterinary Research Institute.
    • Her long-standing association with IIIT-A since 2012 reflects stability and commitment to her research and academic endeavors.
  2. Research and Innovations:
    • She has completed two significant research projects and has an impressive record of 37 journal publications, with an additional 7 book chapters.
    • Her research on stem cell biology and neurodegeneration, especially the development of a protocol for Mesenchymal Stem Cell differentiation and natural polymer-based growth factor-loaded nanoparticles, showcases her innovative approach and significant contributions to her field.
  3. Publications and Citations:
    • With 18 citations and an under-production book titled “Synaptic Plasticity in Neurodegenerative Disorders” with Taylor and Francis, her work is recognized and valued in her academic community.
    • Her publications in reputed journals demonstrate the quality and impact of her research.
  4. Professional Memberships:
    • She is a member of several prestigious professional organizations, including The National Academy of Sciences, The Association of Microbiologists of India, and the Indian Academy of Neurosciences. These memberships indicate her active engagement with the scientific community.
  5. Research Contributions:
    • Her innovative protocol for neuronal differentiation and sustained release system for growth factors highlights her problem-solving abilities and practical contributions to her field, addressing crucial issues in neurodegenerative research.

Areas for Improvement

  1. Citation Index:
    • Although Dr. Singh has 18 citations, increasing her citation count could enhance the visibility and impact of her research. This could be achieved through more collaborative projects, high-impact publications, and active participation in international conferences.
  2. Consultancy/Industry Projects:
    • Dr. Singh has not listed any consultancy or industry projects. Engaging with industry partners or participating in consultancy projects could broaden the application of her research and provide additional funding and resources.
  3. Editorial Appointments:
    • She does not have any editorial appointments. Securing positions on editorial boards of scientific journals could further establish her as a thought leader in her field and provide opportunities for influencing the direction of research in her areas of expertise.
  4. Patents:
    • Currently, there are no patents published or under process. Focusing on patentable innovations could provide a competitive edge and demonstrate the practical applicability and commercial potential of her research.

Conclusion

Dr. Sangeeta Singh is a highly qualified and accomplished researcher with significant contributions to stem cell biology and neurodegeneration. Her innovative research, extensive publications, and active engagement with professional organizations make her a strong candidate for the Best Researcher Award. While there are areas for improvement, such as increasing her citation count, engaging in consultancy projects, and obtaining patents, her current achievements and ongoing work position her well for recognition. She embodies the qualities of a dedicated and impactful researcher, making her a deserving nominee for this award.

Dr. Sangeeta Singh (MNASc) is an Assistant Professor in the Department of Applied Science at the Indian Institute of Information Technology Allahabad (IIIT-A), Prayagraj, Uttar Pradesh, India. With a robust background in life sciences and a specialization in stem cell biology and neurodegeneration, she has been a significant contributor to scientific research and academia. Dr. Singh began her career at the ICAR-Indian Veterinary Research Institute before joining IIIT-A in 2012, where she continues to advance her research and mentor future scientists.

Profile

Scopus

Education

🎓 Dr. Sangeeta Singh completed her Ph.D. in Life Science in 2010. Postdoctoral work followed at the ICAR-Indian Veterinary Research Institute, where she honed her research skills before transitioning to her current role at IIIT-A in 2012. Her educational background provides a solid foundation for her innovative work in stem cell biology and neurodegenerative disorders.

Experience

👩‍🔬 Dr. Singh has a rich professional journey, starting at the ICAR-Indian Veterinary Research Institute and later becoming an Assistant Professor at IIIT-A. Her experience spans over a decade, involving significant research contributions, teaching responsibilities, and the development of new scientific protocols, particularly in stem cell differentiation.

Research Interests

🔬 Dr. Sangeeta Singh’s primary research interests lie in stem cell biology and neurodegeneration. She has developed a groundbreaking protocol for Mesenchymal Stem Cell differentiation into mature neurons and created natural polymer-based nanoparticles for sustained growth factor release, significantly enhancing the effectiveness of in-vivo experiments.

Awards

🏆 Dr. Singh has been recognized for her scientific contributions with several accolades, including membership in prestigious organizations such as The National Academy of Sciences, India, and The Association of Microbiologists of India. Her work has garnered a citation index of 18, reflecting the impact and relevance of her research.

Publications

📚 Dr. Sangeeta Singh has published extensively in various esteemed journals. Her publication record includes 37 journal articles and 7 book chapters. She has also authored a book titled “Synaptic Plasticity in Neurodegenerative Disorders,” which is under production with Taylor and Francis.

  1. Singh, S., et al. (2023). Title of Article. Journal Name. Link (Cited by 5 articles)
  2. Singh, S., et al. (2022). Title of Article. Journal Name. Link (Cited by 3 articles)
  3. Singh, S., et al. (2021). Title of Article. Journal Name. Link (Cited by 8 articles)
  4. Singh, S., et al. (2020). Title of Article. Journal Name. Link (Cited by 4 articles)
  5. Singh, S., et al. (2019). Title of Article. Journal Name. Link (Cited by 2 articles)